Peggy Scherle

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Positive Breast Cancer

Top Venues

Science advances

Cancer research communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jack Carter, Michael Hulse, Monisha Sivakumar, Jessica Burtell, Venkat Thodima, Min Wang, Anjana Agarwal, Komali Vykuntam, Jacob Spruance, Neha Bhagwat, Joseph Rager, Bruce A Ruggeri, Peggy Scherle, Koichi Ito
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. Cancer research communications (2023)
Pu Zhang, Lindsey T Brinton, Mehdi Gharghabi, Steven Sher, Katie Williams, Matthew Cannon, Janek S Walker, Daniel Canfield, Larry Beaver, Casey B Cempre, Hannah Phillips, Xuyong Chen, Pearlly S Yan, Amy Lehman, Peggy Scherle, Min Wang, Kris Vaddi, Robert A Baiocchi, Ruoning Wang, Deepa Sampath, Lapo Alinari, James S Blachly, Rosa Lapalombella
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions. Science advances 8 (37) (2022)
Johanna M Schafer, Brian D Lehmann, Paula I Gonzalez Ericsson, Clayton B Marshall, J Scott Beeler, Lindsay N Redman-Rivera, Hailing Jin, Violeta Sanchez, Matthew C Stubbs, Peggy Scherle, Kimberly N Johnson, Quanhu Shen, Joseph T Roland, Joshua A Bauer, Yu Shyr, A Bapsi Chakravarthy, Bret C Mobley, Scott W Hiebert, Justin M Balko, Melinda E Sanders, Phillip C C Liu, Jennifer A Pietenpol
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors. Science translational medicine 12 (534) (2021)